Alpha-indolyl pyrrolo [1, 2-a] indole derivative and preparation method thereof

By using a 3,5-bis(trifluoromethyl)phenylnaphthylphosphonic acid catalyst to synthesize α-indolylpyrrolo[1,2-a]indole derivatives at low temperatures, the high-temperature and high-cost problems of existing technologies have been solved, realizing an efficient and economical synthesis method and providing a drug skeleton with antimalarial activity.

CN118955508AActive Publication Date: 2024-11-15ZHEJIANG UNIV
View PDF 3 Cites 0 Cited by

Patent Information

Application Number
CN202411029171.7
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-07-30
Publication Date
2024-11-15
Estimated Expiration
2044-07-30

AI Technical Summary

Technical Problem

Existing technologies make it difficult to efficiently synthesize α-indolylpyrrolo[1,2-a]indole derivatives with chiral centers, and the synthesis process requires metal catalysts and high-temperature conditions, resulting in high costs.

Method used

Using 3,5-bis(trifluoromethyl)phenylbinaphthylphosphonic acid as a catalyst, a series reaction was carried out with α-indoleylpropynyl alcohols and indole compounds at low temperature. The products were separated by column chromatography, avoiding the use of metal catalysts and high-temperature conditions.

Benefits of technology

A highly optically active α-indolylpyrrolo[1,2-a]indole derivative was synthesized under mild conditions, reducing costs and providing the core skeleton for the antimalarial drugs isoborreverine and dimethyl isoborreverine.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118955508A_ABST
    Figure CN118955508A_ABST
Patent Text Reader

Abstract

The invention discloses an alpha-indolyl pyrrolo [1, 2-a] indole derivative and a preparation method thereof, and the alpha-indolyl pyrrolo [1, 2-a] indole derivative is a levorotatory or dextrorotatory optical active body or racemate with the following structural formula: # imgabs0. The preparation method comprises the following steps: taking alpha-indolyl propargyl alcohol compounds and indole compounds as raw materials, taking 3, 5-bis (trifluoromethyl) phenyl binaphthyl phosphoric acid as a catalyst, and carrying out a reaction at the temperature of 60-80 DEG C to obtain the alpha-indolyl pyrrolo [1, 2-a] indole derivative. And reacting in an organic solvent to obtain the alpha-indolyl pyrrolo [1, 2-a] indole derivative. According to the present invention, the alpha-indolyl pyrrolo [1, 2-a] indole derivative is synthesized by using the organic phosphoric acid to catalyze the cascade reaction of the two components, the reaction condition is mild, the process is simple, the operation is convenient, and the obtained product is the core skeleton of the indole base of the two natural products such as the antimalarial drug isoborreverine and dimetyl isoborreverine, such that the important significance is provided for the synthesis of the natural product analogue.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the technical field of drug synthesis, and specifically relates to α-indolyl pyrrolo[1,2-a]indole derivatives and preparation methods thereof. Background Art

[0002] α-Indolylpyrrolo[1,2-a]indole derivatives are an important class of organic compounds and are the core skeletons of two natural indole bases, the antimalarial drugs isoborreverine and dimethyl isoborreverine.

[0003] Antimalarial natural product: isoborreverine anddimethylisoborreverine

[0004]

[0005] Therefore, the study and synthesis of α-indolylpyrrolo[1,2-a]indole derivatives with chiral centers has become an important goal for drug synthesis. In addition, indole and its derivatives also have important pharmacological activities. Compounds containing indole ring structural units are widely present in nature and are the most common type of alkaloids discovered so far, accounting for one-fifth of all alkaloids. Due to the unique biological properties of indole compounds, they have extremely wide applications in research fields such as organic synthesis, materials science, agricultural chemistry and pharmacology. It can be expected that molecules with chiral α-indolylpyrrolo[1,2-a]indole derivatives are likely to have high biological activity and have potential research value in the development and synthesis of drug intermediates. Summary of the invention

[0006] The purpose of the present invention is to provide an α-indolyl pyrrolo[1,2-a]indole derivative and a preparation method thereof.

[0007] The α-indolylpyrrolo[1,2-a]indole derivative of the present invention is a levorotatory or dextrorotatory optically active form or racemic form having the following structural formula:

[0008]

[0009] Where: R 1 ~R 4 Each independently selected from H, halogen, methyl, ethyl, phenyl, cyclohexyl, methoxy, Ar 1 ,Ar 2 Each is independently selected from phenyl, phenyl with a substituent, naphthyl, thienyl, and the substituent is selected from halogen, methyl, ethyl, phenyl, cyclohexyl, methoxy, ethoxy, propoxy, and butoxy.

[0010] The structural formula of the α-indolylpyrrolo[1,2-a]indole derivative is preferably one of the following structural formulas:

[0011]

[0012] The preparation method of α-indolyl pyrrolo[1,2-a]indole derivatives of the present invention comprises: using α-indolyl propynol compounds and indole compounds as raw materials, using 3,5-bistrifluoromethylphenyl binaphthyl phosphonic acid as a catalyst, reacting in an organic solvent at low temperature for 10-24 hours, and purifying to obtain α-indolyl pyrrolo[1,2-a]indole derivatives;

[0013] The 3,5-bis(trifluoromethylphenyl)binaphthylphosphonic acid is a compound having the structural formula (1), which can be a left-handed or right-handed optically active form or a racemic form:

[0014]

[0015] The structure of the α-indolyl propynyl alcohol compound is shown in the following formula (2):

[0016]

[0017] The structure of the indole compound is shown in the following formula (3):

[0018]

[0019] In the present invention, the α-indolyl propynyl alcohol compound is preferably one of the following compounds:

[0020]

[0021] In the present invention, the indole compound is preferably one of the following compounds:

[0022]

[0023] In the present invention, the organic solvent is one or more of monofluorodichloroethane, dichloromethane, 1,2-dichloroethane, toluene, benzene, chloroform, tetrahydrofuran, fluorobenzene, chlorobenzene or acetone.

[0024] In the present invention, the molar ratio of the α-indolyl propargyl alcohol compound to the indole compound is 1:1, and the molar ratio of the 3,5-bistrifluoromethylphenyl binaphthyl phosphoric acid catalyst to the α-indolyl propargyl alcohol compound is 1:10; and the reaction temperature is -10-60°C.

[0025] After the reaction is completed, the final product is separated and the catalyst is recovered by column chromatography. The eluent of the column chromatography is a mixed solvent of dichloromethane / petroleum ether or ethyl acetate / petroleum ether. The further preferred volume ratio of dichloromethane / petroleum ether is 1:3, and the volume ratio of ethyl acetate / petroleum ether is 1:10-30.

[0026] Reaction equation of the present invention is as follows:

[0027]

[0028] Compared with the prior art, the present invention has the following advantages:

[0029] 1) No metal catalysis is required and the reaction can be carried out under mild conditions;

[0030] 2) Indoles containing substituents are widely available as reaction substrates; α-indolyl propynyl alcohol compounds can be easily prepared from α-indolecarboxylic acid and its derivatives, which reduces the preparation cost of the final product;

[0031] 3) It is possible to obtain highly optically active chiral α-indolylpyrrolo[1,2-a]indole derivatives;

[0032] 4) The product is the core skeleton of a natural product analogue with antimalarial pharmacological activity.

[0033] In summary, the present invention utilizes a catalytic two-component tandem reaction method to synthesize α-indolyl pyrrolo[1,2-a]indole derivatives, the reaction conditions are mild, the process is simple, and the operation is convenient. The obtained product is the core skeleton of the antimalarial drugs isoborreverine and dimethyl isoborreverine. References include Organic Letters. 2009, 11 (2), 329-332; Chirality. 2013, 27, 14-17. This will be of great significance for the synthesis of analogs of this type of drugs. DETAILED DESCRIPTION

[0034] The following examples will help to understand the present invention, but are not intended to limit the present invention.

[0035] Example 1

[0036] Substrate synthesis

[0037] The synthesis method of the α-indolyl propynyl alcohol compound is as follows:

[0038]

[0039] At 0℃N 2Under the conditions, a mixture containing indole-2-carboxylic acid S1 (25 mmol, 1.0 equivalent), 1-hydroxybenzotriazole (HOBt, 336 mg, 2.5 mmol, 0.1 equivalent), N,O-dimethylhydroxylamine hydrochloride (2.42 g, 25 mmol, 1.0 equivalent), Et 3 N (7.0mL, 50mmol, 2.0 equivalents) and DCM (50mL) were added dropwise to a DCM (20mL) solution of carbodiimide hydrochloride (EDCI, 5.27g, 27.5mmol, 1.2 equivalents). The mixture was stirred at room temperature for 12 hours, then quenched with water (50mL), the organic layer was separated, and anhydrous Na 2 SO 4 The residue was dried and concentrated under reduced pressure and purified by silica gel column chromatography to give the desired Weinreb amide S2.

[0040] At -78°C 2 Under the conditions, a solution of n-butyl lithium in n-hexane (2.5 M, 8 mL, 20.0 mmol, 2.0 equiv) was added dropwise to a round-bottom flask containing aryl bromide (20 mmol, 2.0 equiv) and THF (20 mL). The mixture was stirred at -78 °C for 30 min, and then a solution of the above Weinreb amide S2 (10 mmol, 1.0 equiv) in THF (20 mL) was slowly added via syringe. The resulting mixture was heated to room temperature and stirred for 1 h, and then NH 4 The reaction was quenched with aqueous Cl solution (20 mL), extracted with ethyl acetate (30 mL × 3), washed with water (30 mL × 2), combined the organic layers, and washed with anhydrous Na 2 SO 4 The product was dried, concentrated under reduced pressure and purified by silica gel column chromatography to obtain the desired ketone derivative S3.

[0041] At -78°C 2 Under the conditions, n-butyl lithium in n-hexane solution (2.5M, 2.4mL, 6.0mmol, 3.0 equivalents) was slowly added to a solution of aryl alkyne (6mmol, 3.0 equivalents) in THF (10mL). The resulting mixture was stirred at -78°C for 30 minutes. Then, a solution of ketone derivative S3 (2mmol, 1.0 equivalents) in THF (10mL) was added. The mixture was slowly heated to room temperature and then stirred overnight. Saturated NH 4 The reaction was quenched with aqueous Cl solution (10 ml). The reaction mixture was extracted with ethyl acetate (2 × 10 mL). The organic layers were combined and washed with anhydrous Na 2 SO 4 After drying, filtering and concentration, the desired substrate α-indolyl propynyl alcohol compound S4 was obtained by purification by silica gel column chromatography.

[0042] The above method can be used to prepare a series of α-indolyl propynyl alcohol compounds, as shown below:

[0043] 1-(1H-indol-2-yl)-1,3-diphenyl-prop-2-yn-1-ol Structural formula:

[0044]

[0045] Appearance: Yellow solid

[0046] The eluent for silica gel column chromatography was petroleum ether / ethyl acetate = 20:1-8:1, the yield was 92%, and the product was characterized as follows:

[0047] 1 H NMR (400 MHz, CDCl 3 )δ8.35(s,1H),7.76(d,J=8.0Hz,2H),7.61(d,J=7.8Hz,1H),7.58–7.50(m,2H),7.37(ddt,J=18 .5,12.5,7.5Hz,7H),7.20(t,J=7.6Hz,1H),7.12(t,J=7.4Hz,1H),6.62(s,1H),3.11(s,1H)ppm.

[0048] 3-(4-bromophenyl)-1-(1H-indol-2-yl)-1-phenyl-prop-2-yn-1-ol Structural formula:

[0049]

[0050] Appearance: White solid

[0051] The eluent for silica gel column chromatography was petroleum ether / ethyl acetate = 20:1-8:1, the yield was 93%, and the product was characterized as follows:

[0052] 1 H NMR (400 MHz, CDCl 3 )δ8.31(s,1H),7.72(d,J=7.9Hz,2H),7.60(d,J=7.8Hz,1H),7.49(d,J=7.9Hz,2H),7.44–7.34(m,5H ),7.32(d,J=8.1Hz,1H),7.20(t,J=7.6Hz,1H),7.12(t,J=7.4Hz,1H),6.60(s,1H),3.10(s,1H)ppm.

[0053] 1-(1H-indol-2-yl)-1-phenyl-3-(thiophen-2-yl)-prop-2-yn-1-ol Structural formula:

[0054]

[0055] Appearance: brown solid

[0056] The eluent for silica gel column chromatography was petroleum ether / ethyl acetate = 20:1-8:1, the yield was 83%, and the product was characterized as follows:

[0057] 1 H NMR (400 MHz, CDCl 3 )δ8.34(s,1H),7.74(d,J=7.9Hz,2H),7.60(d,J=7.8Hz,1H),7.57–7.49(m,1H),7.40(td,J=11.2,9.4,4 .5Hz,3H),7.33–7.26(m,2H),7.19(d,J=5.1Hz,2H),7.12(t,J=7.4Hz,1H),6.59(s,1H),3.11(s,1H)ppm.

[0058] Example 2

[0059] 1-(1H-indol-2-yl)-1,3-diphenyl-prop-2-yn-1-ol (0.05 mmol), 3-methylindole (0.05 mmol), (R)-3,5-bis(trifluoromethyl)phenylbinaphthylphosphonic acid) (0.005 mmol) of the above structural formula (1), 3A molecular sieve (50 mg) were added to the reaction flask, and 1 mL of monofluorodichloroethane was injected. The reaction was carried out at -10°C for 24 hours. After the reaction was completed, silica gel column chromatography was directly used, and the eluent was dichloromethane / petroleum ether = 1:3 to obtain the corresponding optically active α-indolylpyrrolo[1,2-a]indole derivative with a yield of 70%. The product was characterized as follows:

[0060] Structural formula:

[0061]

[0062] Appearance: white solid;

[0063] mp221-223℃;

[0064] Optical purity: 90%ee, 99%ee (after recrystallization);

[0065] HPLC analysis conditions: (Dasero chiral column, the same below) Chiralpak AD-H (n-hexane / i-PrOH=90 / 10, 1.0 mL / min), t R (minor)6.427min,t R (major)11.035min;

[0066] Optical rotation: [α] D 20 = +13°(c 1.00,CH 2 Cl 2 );

[0067] 1 H NMR (400 MHz, CDCl 3 )δ7.90(s,1H),7.72–7.67(m,2H),7.65(d,J=7.7Hz,1H),7.57(d,J=7.7Hz,1H),7.51–7.42(m,3H),7.37(dq,J=7.2,3. 9Hz,5H),7.23(d,J=8.1Hz,1H),7.17–7.12(m,1H),7.12–7.02(m,4H),6.67(s,1H),6.55–6.49(m,1H),2.41(s,3H)ppm;

[0068] HRMS m / z(ESI + ): Calculated value C 32 H 25 N 2 ([M+H] + )437.2012, detection value 437.2010.

[0069] Example 3

[0070] 1-(5-bromo-1H-indol-2-yl)-1,3-diphenyl-prop-2-yn-1-ol (0.05 mmol), 3-methylindole (0.05 mmol), (R)-3,5-bis(trifluoromethyl)phenylbinaphthylphosphonic acid) (0.005 mmol) of the above structural formula (1), 3A molecular sieve (50 mg) were added to the reaction flask, and 1 mL of monofluorodichloroethane was injected. The reaction was carried out at -10°C for 24 hours. After the reaction was completed, silica gel column chromatography was directly used, and the eluent was dichloromethane / petroleum ether = 1:3 to obtain the corresponding optically active α-indolylpyrrolo[1,2-a]indole derivative with a yield of 84%. The product was characterized as follows:

[0071] Structural formula:

[0072]

[0073] Appearance: white solid;

[0074] mp161-163℃;

[0075] Optical purity: 93%ee;

[0076] HPLC analysis conditions: Chiralpak AD-H (n-hexane / i-PrOH=80 / 20, 1.0 mL / min), t R (major)6.227min,t R (minor)7.373min;

[0077] Optical rotation: [α] D 20 = +20°(c 1.00,CH 2 Cl 2 );

[0078] 1 H NMR (400 MHz, CDCl 3 )δ7.93(s,1H),7.71–7.62(m,4H),7.52–7.42(m,3H),7.40–7.32(m,5H),7.21(dd,J=8.7, 1.9Hz,1H),7.13–7.00(m,4H),6.64(s,1H),6.45(dd,J=2.2,0.9Hz,1H),2.40(s,3H)ppm;

[0079] HRMS m / z(ESI + ): Calculated value C 32 H 24 Bn 2 ([M+H] + )517.1097, detection value 517.1095.

[0080] Example 4

[0081] 1-(3-methyl-1H-indol-2-yl)-1,3-diphenyl-prop-2-yn-1-ol (0.05 mmol), 3-methylindole (0.05 mmol), (R)-3,5-bis(trifluoromethyl)phenylbinaphthylphosphonic acid) (0.005 mmol) shown in the above structural formula (1) were added to the reaction flask, and 1 mL of monofluorodichloroethane was injected. The reaction was carried out at 0° C. for 24 hours. After the reaction was completed, silica gel column chromatography was directly used, and the eluent was ethyl acetate / petroleum ether = 1:30 to obtain the corresponding optically active α-indolylpyrrolo[1,2-a]indole derivative with a yield of 85%. The product was characterized as follows:

[0082] Structural formula:

[0083]

[0084] Appearance: white solid;

[0085] mp155-157℃;

[0086] Optical purity: 91%ee;

[0087] HPLC analysis conditions: Chiralpak AD-H (n-hexane / i-PrOH=90 / 10, 1.0 mL / min), t R (major)5.075min,t R (minor)6.921min;

[0088] Optical rotation: [α] D 20 = +212°(c 1.00,CH 2 Cl 2 );

[0089] 1 H NMR (400 MHz, CDCl 3 )δ7.85(s,1H),7.67–7.57(m,3H),7.51(dd,J=6.9,1.9Hz,1H),7.45–7.33(m,5H),7.33–7.24(m,3H) ,7.17–7.13(m,1H),7.13–7.03(m,3H),7.03–6.94(m,2H),6.69(s,1H),2.35(s,3H),2.01(s,3H)ppm;

[0090] HRMS m / z(ESI + ): Calculated value C 33 H 27 N 2 ([M+H] + )451.2169, detected value 451.2168.

[0091] Example 5

[0092] 1-(1H-indol-2-yl)-1-phenyl-3-(thiophen-2-yl)-prop-2-yn-1-ol (0.05 mmol), 3-methylindole (0.05 mmol), (R)-3,5-bis(trifluoromethyl)phenylbinaphthylphosphonic acid) (0.005 mmol) of the above structural formula (1), 3A molecular sieve (50 mg) were added to the reaction flask, and 1 mL of monofluorodichloroethane was injected. The reaction was carried out at -10°C for 24 hours. After the reaction was completed, silica gel column chromatography was directly used, and the eluent was dichloromethane / petroleum ether = 1:3 to obtain the corresponding optically active α-indolylpyrrolo[1,2-a]indole derivative with a yield of 72%. The product was characterized as follows:

[0093] Structural formula:

[0094]

[0095] Appearance: white solid;

[0096] mp>300℃;

[0097] Optical purity: 90%ee;

[0098] HPLC analysis conditions: Chiralpak AD-H (n-hexane / i-PrOH=80 / 20, 1.0 mL / min), t R (minor)6.321min,t R (major)10.095min;

[0099] Optical rotation: [α] D 20 = +55°(c 1.00,CH 2 Cl 2 );

[0100] 1 H NMR (400 MHz, CDCl 3 )δ7.88(s,1H),7.65(d,J=7.7Hz,2H),7.56(d,J=7.7Hz,1H),7.43(dd,J=4.9,3.0Hz,1H),7.39(d,J=1 2.3Hz,6H),7.21(d,J=7.9Hz,1H),7.17–7.03(m,5H),6.69(s,1H),6.53–6.48(m,1H),2.50(s,3H)ppm;

[0101] HRMS m / z(ESI + ): Calculated value C 30 H 23 N 2 S([M+H] + )443.1576, detected value 443.1577.

[0102] Example 6

[0103] 1-(4-bromophenyl)-1-(1H-indol-2-yl)-3-phenyl-prop-2-yn-1-ol (0.05mmol), 3-methylindole (0.05mmol), (R)-3,5-bis(trifluoromethylphenyl)binaphthylphosphonic acid (0.005mmol) of the above structural formula (1), 3A molecular sieve (50mg) were added to the reaction flask, and 1mL of monofluorodichloroethane was injected. The reaction was carried out at -10°C for 24 hours. After the reaction was completed, silica gel column chromatography was directly used, and the eluent was dichloromethane / petroleum ether = 1:3 to obtain the corresponding optically active α-indolylpyrrolo[1,2-a]indole derivative with a yield of 80%. The product was characterized as follows:

[0104] Structural formula:

[0105]

[0106] Appearance: white solid;

[0107] mp275-277℃;

[0108] Optical purity: 95%ee;

[0109] HPLC analysis conditions: Chiralpak AD-H (n-hexane / i-PrOH=80 / 20, 1.0 mL / min), t R (minor)7.302min,t R (major)11.101min;

[0110] Optical rotation: [α] D 20 =-45°(c 1.00,CH 2 Cl 2 );

[0111] 1 H NMR (400 MHz, CDCl 3 )δ7.89(s,1H),7.71–7.62(m,3H),7.58(d,J=7.7Hz,1H),7.48(td,J=8.6,6.4Hz,5H),7.26–7.20(m,3H),7.18–7.13(m,1H ),7.11(ddd,J=7.9,3.8,1.5Hz,2H),7.04(td,J=7.9,7.4,3.7Hz,2H),6.60(s,1H),6.51(d,J=2.2Hz,1H),2.40(s,3H)ppm;

[0112] HRMS m / z(ESI + ): Calculated value C 32 H24 Bn 2 ([M+H] + )515.1117, detection value 515.1110.

[0113] Example 7

[0114] 3-(4-bromophenyl)-1-(1H-indol-2-yl)-1-phenyl-prop-2-yn-1-ol (0.05mmol), 3-methylindole (0.05mmol), (R)-3,5-bis(trifluoromethylphenyl)binaphthylphosphonic acid (0.005mmol) of the above structural formula (1), 3A molecular sieve (50mg) were added to the reaction flask, and 1mL of monofluorodichloroethane was injected. The reaction was carried out at -10°C for 24 hours. After the reaction was completed, silica gel column chromatography was directly used, and the eluent was dichloromethane / petroleum ether = 1:3 to obtain the corresponding optically active α-indolylpyrrolo[1,2-a]indole derivative with a yield of 87%. The product was characterized as follows:

[0115] Structural formula:

[0116]

[0117] Appearance: white solid;

[0118] mp273-275℃;

[0119] Optical purity: 93%ee;

[0120] HPLC analysis conditions: Chiralpak AD-H (n-hexane / i-PrOH=80 / 20, 1.0 mL / min), t R (minor)5.987min,t R (major)14.842min;

[0121] Optical rotation: [α] D 20 = +10°(c 1.00,CH 2 Cl 2 );

[0122] 1 H NMR (400 MHz, CDCl 3 )δ7.89(s,1H),7.61(ddd,J=26.2,16.7,8.1Hz,6H),7.39(s,5H),7.22(d,J =7.9Hz,1H),7.19–7.04(m,5H),6.67(s,1H),6.52(s,1H),2.41(s,3H)ppm;

[0123] HRMS m / z(ESI + ): Calculated value C 32 H 24 Bn 2 ([M+H] + )517.1097, detected value 517.1132.

[0124] Example 8

[0125] 1-(1H-indol-2-yl)-3-(naphthalene-2-yl)-1-phenyl-prop-2-yn-1-ol (0.05 mmol), 3-methylindole (0.05 mmol), (R)-3,5-bis(trifluoromethyl)phenylbinaphthylphosphonic acid) (0.005 mmol) of the above structural formula (1), 3A molecular sieve (50 mg) were added to the reaction flask, and 1 mL of monofluorodichloroethane was injected. The reaction was carried out at -10°C for 24 hours. After the reaction was completed, silica gel column chromatography was directly used, and the eluent was dichloromethane / petroleum ether = 1:3 to obtain the corresponding optically active α-indolylpyrrolo[1,2-a]indole derivative with a yield of 58%. The product was characterized as follows:

[0126] Structural formula:

[0127]

[0128] Appearance: white solid;

[0129] mp182-184℃;

[0130] Optical purity: 90%ee;

[0131] HPLC analysis conditions: Chiralpak AD-H (n-hexane / i-PrOH=80 / 20, 1.0 mL / min), t R (minor)5.296min,t R (major)7.825min;

[0132] Optical rotation: [α] D 20 = +15°(c 1.00,CH 2 Cl 2 );

[0133] 1 H NMR (400 MHz, CDCl 3)δ8.19(s,1H),8.01–7.88(m,4H),7.79(dd,J=8.4,1.3Hz,1H),7.68(d,J=7.5Hz,1H),7.63–7.52(m,3H),7.41(dt,J=14.3,7.1 Hz,5H),7.24(d,J=8.1Hz,1H),7.20–7.15(m,1H),7.10(dt,J=9.0,6.9Hz,4H),6.78(s,1H),6.60–6.52(m,1H),2.45(s,3H)ppm;

[0134] HRMS m / z(ESI + ): Calculated value C 36 H 27 N 2 ([M+H] + )487.2169, detected value 487.2174.

[0135] Example 9

[0136] 1-(1H-indol-2-yl)-1,3-diphenyl-prop-2-yn-1-ol (0.05 mmol), 6-bromo-3-methylindole (0.05 mmol), (R)-3,5-bis(trifluoromethyl)phenylbinaphthylphosphonic acid) (0.005 mmol) and 3A molecular sieve (50 mg) were added to the reaction flask, and 1 mL of monofluorodichloroethane was injected. The reaction was carried out at -10°C for 24 hours. After the reaction was completed, silica gel column chromatography was directly used, and the eluent was dichloromethane / petroleum ether = 1:3 to obtain the corresponding optically active α-indolylpyrrolo[1,2-a]indole derivative with a yield of 68%. The product was characterized as follows:

[0137] Structural formula:

[0138]

[0139] Appearance: white solid;

[0140] mp>300℃;

[0141] Optical purity: 94%ee;

[0142] HPLC analysis conditions: Chiralpak AD-H (n-hexane / i-PrOH=80 / 20, 1.0 mL / min), t R (minor)6.135min,t R (major)7.140min;

[0143] Optical rotation: [α] D 20= +95°(c 1.00,CH 2 Cl 2 );

[0144] 1 H NMR (400 MHz, CDCl 3 )δ7.89(s,1H),7.65(d,J=7.7Hz,2H),7.58(d,J=7.9Hz,1H),7.46(q,J=7.4,6.8Hz,4H),7.38(t,J=6.8Hz,3H),7.34 (d,J=7.8Hz,2H),7.28(s,1H),7.20–7.14(m,3H),7.10(t,J=7.4Hz,1H),6.64(s,1H),6.50(s,1H),2.35(s,3H)ppm;

[0145] HRMS m / z(ESI + ): Calculated value C 32 H 24 Bn 2 ([M+H] + )517.1097, detected value 517.1148.

[0146] Example 10

[0147] 1-(1H-indol-2-yl)-1,3-diphenyl-prop-2-yn-1-ol (0.05 mmol), 3-ethylindole (0.05 mmol), (R)-3,5-bis(trifluoromethyl)phenylbinaphthylphosphonic acid) (0.005 mmol) of the above structural formula (1), 3A molecular sieve (50 mg) were added to the reaction flask, and 1 mL of monofluorodichloroethane was injected. The reaction was carried out at -10°C for 24 hours. After the reaction was completed, silica gel column chromatography was directly used, and the eluent was dichloromethane / petroleum ether = 1:3 to obtain the corresponding optically active α-indolylpyrrolo[1,2-a]indole derivative with a yield of 76%. The product was characterized as follows:

[0148] Structural formula:

[0149]

[0150] Appearance: white solid;

[0151] mp139-141℃;

[0152] Optical purity: 92%ee;

[0153] HPLC analysis conditions: Chiralpak AD-H (n-hexane / i-PrOH=80 / 20, 1.0 mL / min), t R(minor)5.044min,t R (major)5.941min;

[0154] Optical rotation: [α] D 20 = +72°(c 1.00,CH 2 Cl 2 );

[0155] 1 H NMR (400 MHz, CDCl 3 )δ7.93(s,1H),7.71(dd,J=11.4,7.9Hz,3H),7.60(d,J=7.6Hz,1H),7.49(q,J=8.0,7.2Hz,3H),7.40(s,5H),7.24(d,J=7.9Hz,1H) ,7.17(t,J=7.4Hz,1H),7.10(dt,J=11.9,7.1Hz,4H),6.67(s,1H),6.54(s,1H),2.93–2.81(m,2H),1.31(dt,J=7.5,3.6Hz,3H)ppm;

[0156] HRMS m / z(ESI + ): Calculated value C 32 H 24 Bn 2 ([M+H] + )517.1097, detected value 517.1148.

[0157] Embodiment 11

[0158] Pharmacological activity test, cytotoxicity assay.

[0159] Human prostate cancer cell line PC-3 was cultured in f12k medium supplemented with 10% fetal bovine serum (FBS) and 1% penicillin-streptomycin stock solution. The cells were cultured in an incubator at 37°C with 5% carbon dioxide.

[0160] The cytotoxicity of the compounds was evaluated by MTT assay using PC-3 cells. Human prostate cancer cells (PC-3) were seeded in 96-well plates at a density of 10,000 cells per well, with 200 μL of full medium per well. After 16 hours of adhesion, the supernatant was removed from the wells, and 200 μL of medium solution containing the sample to be tested was added to each well. 200 μL of PEI aqueous solution (25 kD, 2 mg / mL) was added to the dead control cell group, and 200 μL of serum-free medium was added to the live control cell group. The cell plate was cultured in an incubator at 37°C with 5% carbon dioxide for 4 hours. After the stimulation, the supernatant was removed from the wells, and 100 μL of MTT (0.5 mg / mL) solution was added to each well. The cell plate was further cultured in an incubator at 37°C with 5% carbon dioxide for 4 hours. The supernatant was then removed, and 100 μL of DMSO was added to each well. The culture plate was shaken for 2 min and the optical density (OD) value was read at a wavelength of 570 nm using a microplate reader.

[0161] Viability=([OD] experimental -[OD] blank ) / ([OD] control -[OD] blank )×100%

[0162] The test results show that the half-lethal concentrations of the two compounds prepared in Example 2 and Example 7 exceed their measured concentration ranges, and their half-lethal concentrations are above 300 μM.

[0163] Cytotoxicity test on human prostate cancer cell line PC-3 showed that the two compounds prepared in Example 2 and Example 7 had weak toxicity to PC-3 cells; the compound prepared in Example 10 had IC 50 [μM] is 10.0.

Claims

1. An α-indolylpyrrolo[1,2-a]indole derivative, characterized in that It is a left-handed or right-handed optically active compound or its racemate having the following structural formula: Where: R 1 ~R 4 Each independently selected from H, halogen, methyl, ethyl, phenyl, cyclohexyl, methoxy, Ar 1 ,Ar 2 Each is independently selected from phenyl, phenyl with a substituent, naphthyl, thienyl, and the substituent is selected from halogen, methyl, ethyl, phenyl, cyclohexyl, methoxy, ethoxy, propoxy, and butoxy.

2. The α-indolylpyrrolo[1,2-a]indole derivative according to claim 1, characterized in that The structural formula is preferably one of the following structural formulas:

3. The method for preparing the α-indolylpyrrolo[1,2-a]indole derivative according to claim 1, characterized in that: The method comprises taking an α-indolyl propynol compound and an indole compound as raw materials, taking 3,5-bis(trifluoromethyl)phenylbinaphthylphosphonic acid as a catalyst, reacting in an organic solvent for 10-24 hours, and purifying to obtain an α-indolyl pyrrolo[1,2-a]indole derivative; The 3,5-bis(trifluoromethyl)phenylbinaphthylphosphonic acid is a compound having the structural formula (1), which is a left-handed or right-handed optically active form or a racemic form: The structure of the α-indolyl propynyl alcohol compound is shown in the following formula (2): The structure of the indole compound is shown in the following formula (3):

4. The method for preparing α-indolylpyrrolo[1,2-a]indole derivatives according to claim 3, characterized in that: The α-indolyl propynyl alcohol compound is preferably one of the following compounds:

5. The method for preparing α-indolylpyrrolo[1,2-a]indole derivatives according to claim 3, characterized in that: The indole compound is preferably one of the following compounds:

6. The method for preparing α-indolylpyrrolo[1,2-a]indole derivatives according to claim 3, characterized in that: The organic solvent is one or more of monofluorodichloroethane, dichloromethane, 1,2-dichloroethane, toluene, benzene, chloroform, tetrahydrofuran, fluorobenzene, chlorobenzene or acetone.

7. The method for preparing α-indolylpyrrolo[1,2-a]indole derivatives according to claim 3, characterized in that: The molar ratio of the α-indolyl propargyl alcohol compound to the indole compound is 1:1, and the molar ratio of the 3,5-bistrifluoromethylphenyl binaphthyl phosphoric acid catalyst to the α-indolyl propargyl alcohol compound is 1:10; the reaction temperature is -10-60°C.

Citation Information

Patent Citations

  • Flinderole analogues and process for synthesis thereof

    CN103476775A

  • High-diastereoselectivity polycyclic indole compound as well as synthesis method and application thereof

    CN115572301A

  • Organic electroluminescence device

    US20100051928A1